Gennova Biopharmaceuticals becomes a wholly owned Emcure subsidiary as Samit Mehta takes charge to drive biologics and biosimilars growth.
Read More
Think | Create | Scale
Most Commented News
Gennova Biopharmaceuticals becomes a wholly owned Emcure subsidiary as Samit Mehta takes charge to drive biologics and biosimilars growth.
Read More